MAURA JANOSKI: Open Payments
NPI 1043999006 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,127 in 101 payments from 19 companies in 2025. Trend: 2023 $21 · 2024 $287 · 2025 $2,127
Food & beverage: $2,042Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $427 |
| Janssen Biotech, Inc. | 10 | $250 |
| Ipsen Biopharmaceuticals, Inc | 8 | $216 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $190 |
| Madrigal Pharmaceuticals | 5 | $171 |
| QOL Medical, LLC | 4 | $123 |
| GENZYME CORPORATION | 6 | $122 |
| PFIZER INC. | 4 | $84 |
| Phathom Pharmaceuticals, Inc. | 8 | $60 |
Products named: TREMFYA, IQIRVO, XIFAXAN, REZDIFFRA, DUPIXENT, ENTYVIO, Sucraid, LINZESS.
Industry payments across PA — which companies pay providers there.
